02611nam 2200613Ia 450 991077738090332120230617030751.01-280-04123-497866100412371-4175-2627-092-4-068004-7(CKB)1000000000000392(EBL)284583(OCoLC)55664175(SSID)ssj0000097270(PQKBManifestationID)11120025(PQKBTitleCode)TC0000097270(PQKBWorkID)10116016(PQKB)10551207(MiAaPQ)EBC284583(Au-PeEL)EBL284583(CaPaEBR)ebr10047402(CaONFJC)MIL4123(EXLCZ)99100000000000039220040211d2003 my 0engur|n|---|||||txtccrAdheremce to long-term therapies[electronic resource] evidence for action /edited by Eduardo SabateGeneva World Health Organization20031 online resource (206 p.)Description based upon print version of record.92-4-154599-2 Contents; Preface; Ackowledgement; Scientific writers; Introduction; Take-home messages; Section I - Setting the scene; Section II - Improving adherence rates: guidance for countries; Section III - Disease-specific reviews; Annexes; Where to find a copy of this bookAdherence to therapies is a primary determinant of treatment success. Poor adherence attenuates optimum clinical benefits and therefore reduces the overall effectiveness of health systems. ''Medicines will not work if you do not take them''. Medicines will not be effective if patients do not follow prescribed treatment, yet in developed countries only 50% of patients who suffer from chronic diseases adhere to treatment recommendations. In developing countries, when taken together with poor access to health care, lack of appropriate diagnosis and limited access to medicines, poor adherence is tChronic diseasesTreatmentPatient complianceMedical policyChronic diseasesTreatment.Patient compliance.Medical policy.362.16615.5Sabaté Eduardo1540336World Health Organization.MiAaPQMiAaPQMiAaPQBOOK9910777380903321Adheremce to long-term therapies3791919UNINA